Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Edmonds

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|January 5, 1980
Cross-reactivity between environmental agents and HLA-B2A F Geczy, H V Bashir, K Alexander, et al.
Pathology|July 1, 1995
Aortitis with dissection complicating systemic lupus erythematosusR W Guard, I Gotis-Graham, J P Edmonds, et al.
Journal of Autoimmunity|June 1, 1992
Use of a molecularly cloned human SS.B antigen to detect anti-SS.B antibodiesR A Owe-Young, S Horn, J P Edmonds, et al.
The Journal of Experimental Medicine|September 1, 1986
Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitisA F Geczy, L E McGuigan, J S Sullivan, et al.
Clinical and Experimental Immunology|October 1, 1975
The value of tests for antibodies to DNA in monitoring the clinical course of SLE. A long-term study using the Farr test and the DNA counterimmunoelectrophoretic methodJ P Edmonds, G D Johnson, B M Ansell, et al.
The Journal of Rheumatology|March 1, 1993
New classification of antirheumatic drugs. The evolution of a conceptJ P Edmonds, D L Scott, D E Furst, et al.
Internal Medicine Journal|February 1, 2012
How many life years are lost in patients with rheumatoid arthritis? Secular cause-specific and all-cause mortality in rheumatoid arthritis, and their predictors in a long-term Australian cohort studyM N Lassere, J Rappo, I J Portek, et al.
Human Immunology|December 1, 1982
Immunochemical characterization of Klebsiella antigens which specifically modify an HLA-B27-associated cell-surface componentJ Sullivan, L Upfold, A F Geczy, et al.
Arthritis and Rheumatism|March 1, 1993
Antirheumatic drugs: a proposed new classificationJ P Edmonds, D L Scott, D E Furst, et al.
Annals of the Rheumatic Diseases|July 1, 1986
Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitisL E McGuigan, J K Prendergast, A F Geczy, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|January 5, 1980
Cross-reactivity between environmental agents and HLA-B2A F Geczy, H V Bashir, K Alexander, et al.
Pathology|July 1, 1995
Aortitis with dissection complicating systemic lupus erythematosusR W Guard, I Gotis-Graham, J P Edmonds, et al.
Journal of Autoimmunity|June 1, 1992
Use of a molecularly cloned human SS.B antigen to detect anti-SS.B antibodiesR A Owe-Young, S Horn, J P Edmonds, et al.
The Journal of Experimental Medicine|September 1, 1986
Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitisA F Geczy, L E McGuigan, J S Sullivan, et al.
Clinical and Experimental Immunology|October 1, 1975
The value of tests for antibodies to DNA in monitoring the clinical course of SLE. A long-term study using the Farr test and the DNA counterimmunoelectrophoretic methodJ P Edmonds, G D Johnson, B M Ansell, et al.
The Journal of Rheumatology|March 1, 1993
New classification of antirheumatic drugs. The evolution of a conceptJ P Edmonds, D L Scott, D E Furst, et al.
Internal Medicine Journal|February 1, 2012
How many life years are lost in patients with rheumatoid arthritis? Secular cause-specific and all-cause mortality in rheumatoid arthritis, and their predictors in a long-term Australian cohort studyM N Lassere, J Rappo, I J Portek, et al.
Human Immunology|December 1, 1982
Immunochemical characterization of Klebsiella antigens which specifically modify an HLA-B27-associated cell-surface componentJ Sullivan, L Upfold, A F Geczy, et al.
Arthritis and Rheumatism|March 1, 1993
Antirheumatic drugs: a proposed new classificationJ P Edmonds, D L Scott, D E Furst, et al.
Annals of the Rheumatic Diseases|July 1, 1986
Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitisL E McGuigan, J K Prendergast, A F Geczy, et al.
Pageof 5